APOL1 Kidney Risk Variants Induce Cell Death via Mitochondrial Translocation and Opening of the Mitochondrial Permeability Transition Pore

被引:62
|
作者
Shah, Shrijal S. [1 ]
Lannon, Herbert [1 ]
Dias, Leny [1 ]
Zhang, Jia-Yue [1 ]
Alper, Seth L. [1 ]
Pollak, Martin R. [1 ]
Friedman, David J. [1 ]
机构
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Renal Div, Boston, MA 02115 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2019年 / 30卷 / 12期
基金
美国国家卫生研究院;
关键词
APOL1; mitochondria; chronic kidney disease; focal segmental glomerulosclerosis; genetic renal disease; LIPID-BINDING PROTEIN; DISEASE; CYTOTOXICITY; EXPRESSION; LOCALIZATION; MACHINERIES; RESISTANCE; MECHANISM; IMMUNITY; IMPORT;
D O I
10.1681/ASN.2019020114
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Genetic Variants in Apolipoprotein L1 (APOL1) are associated with large increases in CKD rates among African Americans. Experiments in cell and mouse models suggest that these risk-related polymorphisms are toxic gain-of-function variants that cause kidney dysfunction, following a recessive mode of inheritance. Recent data in trypanosomes and in human cells indicate that such variants may cause toxicity through their effects on mitochondria. Methods To examine the molecular mechanisms underlying APOL1 risk variant-induced mitochondrial dysfunction, we generated tetracycline-inducible HEK293 T-REx cells stably expressing the APOL1 nonrisk G0 variant or APOL1 risk variants. Using these cells, we mapped the molecular pathway from mitochondrial import of APOL1 protein to APOL1-induced cell death with small interfering RNA knockdowns, pharmacologic inhibitors, blue native PAGE, mass spectrometry, and assessment of mitochondrial permeability transition pore function. Results We found that the APOL1 G0 and risk variant proteins shared the same import pathway into the mitochondrial matrix. Once inside, G0 remained monomeric, whereas risk variant proteins were prone to forming higher-order oligomers. Both nonrisk G0 and risk variant proteins bound components of the mitochondrial permeability transition pore, but only risk variant proteins activated pore opening. Blocking mitochondrial import of APOL1 risk variants largely eliminated oligomer formation and also rescued toxicity. Conclusions Our study illuminates important differences in the molecular behavior of APOL1 nonrisk and risk variants, and our observations suggest a mechanism that may explain the very different functional effects of these variants, despite the lack of consistently observed differences in trafficking patterns, intracellular localization, or binding partners. Variant-dependent differences in oligomerization pattern may underlie APOL1's recessive, gain-of-function biology.
引用
收藏
页码:2355 / 2368
页数:14
相关论文
共 50 条
  • [1] APOL1 Kidney-Risk Variants Induce Mitochondrial Fission
    Ma, Lijun
    Ainsworth, Hannah C.
    Snipes, James A.
    Murea, Mariana
    Choi, Young A.
    Langefeld, Carl D.
    Parks, John S.
    Bharadwaj, Manish S.
    Chou, Jeff W.
    Hemal, Ashok K.
    Petrovic, Snezana
    Craddock, Ann L.
    Cheng, Dongmei
    Hawkins, Gregory A.
    Miller, Lance D.
    Hicks, Pamela J.
    Saleem, Moin A.
    Divers, Jasmin
    Molina, Anthony J. A.
    Freedman, Barry, I
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (06): : 891 - 904
  • [2] APOL1 Renal-Risk Variants Induce Mitochondrial Dysfunction
    Ma, Lijun
    Chou, Jeff W.
    Snipes, James A.
    Bharadwaj, Manish S.
    Craddock, Ann L.
    Cheng, Dongmei
    Weckerle, Allison
    Petrovic, Snezana
    Hicks, Pamela J.
    Hemal, Ashok K.
    Hawkins, Gregory A.
    Miller, Lance D.
    Molina, Anthony J. A.
    Langefeld, Carl D.
    Murea, Mariana
    Parks, John S.
    Freedman, Barry I.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (04): : 1093 - 1105
  • [3] APOL1 Kidney Risk Variants and Proteomics
    Chen, Teresa K.
    Surapaneni, Aditya L.
    Arking, Dan E.
    Ballantyne, Christie M.
    Boerwinkle, Eric
    Chen, Jingsha
    Coresh, Josef
    Koettgen, Anna
    Susztak, Katalin
    Tin, Adrienne
    Yu, Bing
    Grams, Morgan E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (05): : 684 - 692
  • [4] APOL1 Risk Variants Impair Multiple Mitochondrial Pathways in a Metabolomics Analysis
    Ma, Lijun
    Palmer, Nicholette D.
    Choi, Young A.
    Murea, Mariana
    Snipes, James A.
    Parks, John S.
    Langefeld, Carl D.
    Freedman, Barry, I
    KIDNEY360, 2020, 1 (12): : 1353 - 1362
  • [5] APOL1 risk variants in kidney transplantation: a modulation of immune cell function
    Malone, Andrew F.
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (22)
  • [6] APOL1 Kidney Disease Risk Variants: An Evolving Landscape
    Dummer, Patrick D.
    Limou, Sophie
    Rosenberg, Avi Z.
    Heymann, Jurgen
    Nelson, George
    Winkler, Cheryl A.
    Kopp, Jeffrey B.
    SEMINARS IN NEPHROLOGY, 2015, 35 (03) : 222 - 236
  • [7] Balancing the genetic risk of APOL1 kidney disease variants
    Kabore, Nongodo Firmin
    Limou, Sophie
    NEPHROLOGIE & THERAPEUTIQUE, 2019, 15 : S79 - S84
  • [8] Tristability in mitochondrial permeability transition pore opening
    Qi, Hong
    Li, Zhi-Chao
    Wang, Shi-Miao
    Wu, Lin
    Xu, Fei
    Liu, Zhi-Long
    Li, Xiang
    Wang, Jia-Zeng
    CHAOS, 2021, 31 (12)
  • [9] The Mechanism of Kidney Disease Due to APOL1 Risk Variants
    Pays, Etienne
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (11): : 2502 - 2505
  • [10] Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection
    Javadov, Sabzali
    Karmazyn, Morris
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2007, 20 (1-4) : 1 - 22